QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
Log in
NYSE:ALB

Albemarle Stock Forecast, Price & News

$135.88
-0.09 (-0.07 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$134.82
Now: $135.88
$138.19
50-Day Range
$90.78
MA: $110.63
$137.66
52-Week Range
$48.89
Now: $135.88
$138.19
Volume1.71 million shs
Average Volume1.50 million shs
Market Capitalization$14.47 billion
P/E Ratio37.96
Dividend Yield1.13%
Beta1.3
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company operates in three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment offers hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. The company serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1994 and is headquartered in Charlotte, North Carolina.
Albemarle logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.08 out of 5 stars


Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
CUSIP01265310
Phone980-299-5700
Employees6,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.59 billion
Cash Flow$8.14 per share
Book Value$40.63 per share

Profitability

Net Income$533.23 million

Miscellaneous

Market Cap$14.47 billion
Next Earnings Date2/17/2021 (Estimated)
OptionableOptionable
$135.88
-0.09 (-0.07 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock been impacted by Coronavirus?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALB stock has increased by 93.9% and is now trading at $135.88.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Albemarle?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 5 sell ratings, 10 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Albemarle?

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Albemarle wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Albemarle
.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Monday, November, 9th. The specialty chemicals company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.78 by $0.31. The specialty chemicals company had revenue of $746.87 million for the quarter, compared to analysts' expectations of $734.75 million. Albemarle had a net margin of 11.77% and a return on equity of 11.96%. Albemarle's revenue was down 15.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.53 EPS.
View Albemarle's earnings history
.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Tuesday, October 27th. Investors of record on Friday, December 11th will be paid a dividend of $0.385 per share on Monday, January 4th. This represents a $1.54 annualized dividend and a dividend yield of 1.13%. The ex-dividend date is Thursday, December 10th.
View Albemarle's dividend history
.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its FY20 earnings guidance on Wednesday, November, 4th. The company provided EPS guidance of $3.80-4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.48. The company issued revenue guidance of $3.05-3.15 billion, compared to the consensus revenue estimate of $3.04 billion.

What price target have analysts set for ALB?

23 brokerages have issued 1-year price objectives for Albemarle's stock. Their forecasts range from $50.00 to $140.00. On average, they anticipate Albemarle's share price to reach $95.92 in the next twelve months. This suggests that the stock has a possible downside of 29.4%.
View analysts' price targets for Albemarle
.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the following people:
  • Mr. Jerry Kent Masters Jr., Pres, CEO & Chairman (Age 59, Pay $150k)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 54, Pay $974.29k)
  • Ms. Karen G. Narwold Esq., Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 60, Pay $861.02k)
  • Mr. Luther C. Kissam IV, Director (Age 55, Pay $2M)
  • Mr. Raphael Goszcz Crawford, Pres of Catalysts Global Bus. Unit (Age 44, Pay $1.01M)
  • Mr. Netha N. Johnson Jr., Pres of Bromine Specialties Global Bus. Unit (Age 49, Pay $1.51M)
  • Mr. John Clarence Barichivich III, VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Mr. Patrick Thompson, Chief Information Officer
  • Ms. Sharon B. McGee, VP of Corp. Devel. & Investor Relations
  • Ms. DeeAnne J. Marlow, Sr. VP & Chief HR Officer (Age 54)

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.06%), State Street Corp (6.09%), KAMES CAPITAL plc (1.06%), ProShare Advisors LLC (1.02%), US Bancorp DE (0.77%) and Charles Schwab Investment Management Inc. (0.66%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle
.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, ProShare Advisors LLC, BlackRock Inc., AXA S.A., Morgan Stanley, US Bancorp DE, Victory Capital Management Inc., and Public Employees Retirement System of Ohio. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle
.

Which major investors are buying Albemarle stock?

ALB stock was purchased by a variety of institutional investors in the last quarter, including Payden & Rygel, First Trust Advisors LP, Standard Life Aberdeen plc, Cibc World Markets Corp, Axel Capital Management LLC, Main Street Research LLC, AQR Capital Management LLC, and KAMES CAPITAL plc. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle
.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $135.88.

How big of a company is Albemarle?

Albemarle has a market capitalization of $14.47 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.